Kidney dysfunction during lenalidomide treatment for AL amyloidosis

Background. Lenalidomide is an immunomodulatory agent used to treat plasma cell dyscrasias. We previously observed worsening of kidney function in a high proportion of patients with AL amyloidosis during lenalidomide treatment. The objective of this study is to characterize alterations in kidney fun...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Specter, Richard, Sanchorawala, Vaishali, Seldin, David C., Shelton, Anthony, Fennessey, Salli, Finn, Kathleen T., Zeldis, Jerome B., Dember, Laura M.
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2011
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3108346/
https://ncbi.nlm.nih.gov/pubmed/20693160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfq482
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker